AQR Capital Management
IRMD icon

AQR Capital Management’s iRadimed IRMD Stock Holding History

AQR Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Buy
15,925
+36
+0.2% +$3.6K ﹤0.01% 2524
2025
Q4 		$1.55M Buy
15,889
+2,524
+19% +$217K ﹤0.01% 2303
2025
Q3 		$951K Buy
13,365
+1,782
+15% +$119K ﹤0.01% 2466
2025
Q2 		$693K Sell
11,583
-4,246
-27% -$233K ﹤0.01% 2427
2025
Q1 		$831K Buy
15,829
+1,108
+8% +$62.3K ﹤0.01% 2140
2024
Q4 		$810K Buy
14,721
+4,218
+40% +$222K ﹤0.01% 2005
2024
Q3 		$528K Buy
10,503
+2,067
+25% +$95.4K ﹤0.01% 2149
2024
Q2 		$371K Buy
+8,436
New +$359K ﹤0.01% 2187
2024
Q1 		– Sell
-4,667
Closed -$222K – 2453
2023
Q4 		$222K Sell
4,667
-5,096
-52% -$214K ﹤0.01% 2178
2023
Q3 		$433K Sell
9,763
-16
-0.2% -$743 ﹤0.01% 1894
2023
Q2 		$467K Buy
+9,779
New +$441K ﹤0.01% 1805
2022
Q4 		– Sell
-16,755
Closed -$504K – 2238
2022
Q3 		$504K Sell
16,755
-9,279
-36% -$323K ﹤0.01% 1779
2022
Q2 		$884K Buy
26,034
+21,181
+436% +$759K ﹤0.01% 1473
2022
Q1 		$218K Buy
+4,853
New +$224K ﹤0.01% 2043
2021
Q1 		– Sell
-10,377
Closed -$237K – 2228
2020
Q4 		$237K Sell
10,377
-20,459
-66% -$473K ﹤0.01% 2039
2020
Q3 		$659K Sell
30,836
-8,691
-22% -$195K ﹤0.01% 1618
2020
Q2 		$917K Sell
39,527
-11,675
-23% -$251K ﹤0.01% 1496
2020
Q1 		$1.09M Sell
51,202
-5,895
-10% -$140K ﹤0.01% 1309
2019
Q4 		$1.33M Sell
57,097
-18,667
-25% -$436K ﹤0.01% 1423
2019
Q3 		$1.59M Buy
75,764
+51,793
+216% +$1.06M ﹤0.01% 1371
2019
Q2 		$490K Buy
23,971
+8,207
+52% +$193K ﹤0.01% 1737
2019
Q1 		$443K Buy
15,764
+6,673
+73% +$175K ﹤0.01% 1845
2018
Q4 		$222K Buy
+9,091
New +$244K ﹤0.01% 2048
2018
Q3 		– Sell
-25,499
Closed -$529K – 2296
2018
Q2 		$529K Sell
25,499
-14,309
-36% -$253K ﹤0.01% 1961
2018
Q1 		$561K Sell
39,808
-22,486
-36% -$320K ﹤0.01% 1872
2017
Q4 		$944K Sell
62,294
-30,981
-33% -$394K ﹤0.01% 1699
2017
Q3 		$895K Sell
93,275
-53,306
-36% -$505K ﹤0.01% 1712
2017
Q2 		$1.26M Buy
146,581
+8,918
+6% +$76.1K ﹤0.01% 1586
2017
Q1 		$1.23M Buy
137,663
+28,345
+26% +$263K ﹤0.01% 1585
2016
Q4 		$1.21M Buy
109,318
+54,011
+98% +$581K ﹤0.01% 1641
2016
Q3 		$940K Buy
55,307
+7,043
+15% +$130K ﹤0.01% 1735
2016
Q2 		$1.05M Buy
48,264
+14,214
+42% +$256K ﹤0.01% 1601
2016
Q1 		$652K Buy
34,050
+19,923
+141% +$381K ﹤0.01% 1726
2015
Q4 		$396K Buy
+14,127
New +$399K ﹤0.01% 1955

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management's IRMD Position: Q1 2026 in Review

AQR Capital Management increased its iRadimed (IRMD) stake by 0.23% in Q1 2026, buying an estimated $3.6K and bringing the position to 15,925 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2524.

AQR Capital Management first reported a position in IRMD in Q4 2015 and has held it in 34 quarters since. The position peaked at $1.59M in Q3 2019. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • AQR Capital Management held 15,925 shares of iRadimed worth $1.53M as of Q1 2026.
  • AQR Capital Management bought 36 iRadimed shares in Q1 2026, an estimated $3.6K.
  • iRadimed made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2524 holding.
  • AQR Capital Management first reported a position in iRadimed in Q4 2015 and has held it in 34 quarters since.
  • AQR Capital Management's iRadimed position peaked at $1.59M in Q3 2019.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.